| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.22 | 9e-06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |